In particular, decreased levels of high-density lipoprotein (HDL) cholesterol and its primary apolipoprotein, apolipoprotein A-I (ApoA-I), have been consistently associated with heightened systemic inflammation, greater disease severity, and reduced survival in individuals with cirrhosis [5]. This evidence concerns the gene APOA1 and Cirrhosis.